Physician profile
Thomas V Robb
NPI 1245327162
$1,110.39
in general payments reported to CMS, 2019-2025
11 companies · $87.93 in 2025
The $87.93 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.78 · 2020: $27.03 · 2021: $43.82 · 2022: $186 · 2023: $477 · 2024: $265 · 2025: $87.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $762 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $761.79 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $390.76 | 2023-2024 | Recell |
| Inari Medical, INC. | $186.48 | 2022 | |
| Kerecis Limited | $125.00 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Janssen Pharmaceuticals, INC | $108.36 | 2023 | Xarelto |
| Kci USA, INC. | $77.97 | 2023 | Prevena, Activ.A.C., V.A.C.Ulta |
| Zimmer Biomet Holdings, INC. | $70.85 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Takeda Pharmaceuticals U.S.A., INC. | $24.31 | 2023 | Gattex |
| Avanos Medical | $22.78 | 2019 | |
| Solventum Corporation | $19.44 | 2025 | V.A.C.Ulta |
| Medtronic, INC. | $15.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Robb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.